Skip Navigation
Markets
Pre-Markets
U.S. Markets
Currencies
Prediction Markets
Cryptocurrency
Futures & Commodities
Bonds
Funds & ETFs
Business
Economy
Finance
Health & Science
Media
Real Estate
Energy
Climate
Transportation
Investigations
Industrials
Retail
Wealth
Sports
Life
Small Business
Investing
Personal Finance
Fintech
Financial Advisors
Options Action
ETF Street
Buffett Archive
Earnings
Trader Talk
Tech
Cybersecurity
AI
Enterprise
Internet
Media
Mobile
Social Media
CNBC Disruptor 50
Tech Guide
Politics
White House
Policy
Defense
Congress
Expanding Opportunity
Video
Latest Video
Full Episodes
Livestream
Live Audio
Live TV Schedule
CNBC Podcasts
CEO Interviews
CNBC Documentaries
Digital Originals
Watchlist
Investing Club
Trust Portfolio
Analysis
Trade Alerts
Meeting Videos
Homestretch
Jim's Columns
Education
Subscribe
PRO
Pro News
Josh Brown
Mike Santoli
Calls of the Day
My Portfolio
Livestream
Full Episodes
Stock Screener
Market Forecast
Options Investing
Chart Investing
Subscribe
Livestream
Menu
Make It
select
USA
INTL
Livestream
Search quotes, news & videos
Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics
Video
Watchlist
Investing Club
PRO
Livestream
Menu
Business News
Health and Science
Coronavirus
Biotech and Pharma
Health Insurance
Hospitals
Science
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial
Annika Kim Constantino
Tue, Feb 3rd 2026
Pfizer beats quarterly estimates despite Covid product decline, reaffirms outlook
Annika Kim Constantino
Tue, Feb 3rd 2026
Merck tops quarterly estimates, posts modest outlook as generic competition looms
Annika Kim Constantino
Tue, Feb 3rd 2026
Eli Lilly CEO: Medicare coverage of obesity drugs could support pill launch
Annika Kim Constantino
Fri, Jan 30th 2026
Eli Lilly plans $3.5 billion Pennsylvania manufacturing plant for obesity drugs
Annika Kim Constantino
Fri, Jan 30th 2026
Personal Finance
As ACA subsidies expire, health costs emerge as top economic worry for voters: survey
Fri, Jan 30th 2026
CNBC Cures
Breakthrough drug helps 11-year-old battle rare neurological gene mutation
Fri, Jan 30th 2026
Healthy Returns
Healthy Returns: 15 drugs added to Medicare price negotiations
Wed, Jan 28th 2026
Analysis
Danaher stock fails to rise on solid earnings — leading us to question what's next
Wed, Jan 28th 2026
Health and Science
UnitedHealth posts earnings beat, soft revenue guidance as insurer plots turnaround
Tue, Jan 27th 2026
Trending Now
1
32-year-old woman and her husband built her mom a tiny home in their backyard for under $32,000—take a look inside
2
Fed's Stephen Miran resigns from White House post
3
World’s largest jeweler falls after analysts warn it will be hit by volatile silver price
4
Asian software stocks plunge after U.S. peers decline on fears over AI-led disruption
5
Gold and silver rebound, pulling global mining stocks and precious metal ETFs higher
More In Health and Science
Health and Science
Next up in weight loss drugs: More pills, easier access and drug combinations
Fri, Jan 23rd 2026
Healthy Returns
Healthy Returns: Structure Therapeutics CEO on obesity pills, future of GLP-1s
Wed, Jan 21st 2026
Tech
Amazon launches AI health-care tool for One Medical members
Wed, Jan 21st 2026
Tech
OpenEvidence, the 'ChatGPT for doctors,' doubles valuation to $12 billion
Wed, Jan 21st 2026
Analysis
Another alliance of health care and AI signals why pharma stocks could be back
Tue, Jan 20th 2026
Health and Science
Drug pricing, patent losses, deals: What pharma execs see ahead in the industry
Tue, Jan 20th 2026
Health and Science
Novo Nordisk shares rise after Wegovy obesity pill has 'solid' start to launch
Fri, Jan 16th 2026
CNBC Cures
Keeping U.S. biotech ahead of China's could help rare disease patients, experts say
Tue, Jan 20th 2026
Healthy Returns
Healthy Returns: Novo CEO on GLP-1 pricing, and more insights from the JPM conference
Fri, Jan 16th 2026
Tech
OpenAI acquires health-care technology startup Torch for $60 million: Source
Mon, Jan 12th 2026
CNBC Cures
Thanks for your support, here’s how to connect with us
Mon, Jan 12th 2026
Health and Science
2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market
Sat, Jan 10th 2026
Healthy Returns
Healthy Returns: What to expect from pharma at the JPM conference
Fri, Jan 9th 2026
Biotech and Pharma
Europe's best-performing blue-chip stock has become a prime takeover target
Fri, Jan 9th 2026
CNBC Investigations
Patient advocates urge U.S. court to halt overseas prescription drug operations
Thu, Jan 8th 2026
CNBC Cures
CNBC launches CNBC Cures to help 30 million Americans with rare diseases
Sat, Jan 10th 2026
CNBC Cures
CNBC's Becky Quick details daughter's rare disease journey
Sat, Jan 10th 2026
Tech
OpenAI launches ChatGPT Health to connect user medical records, wellness apps
Wed, Jan 7th 2026
Food & Beverage
RFK Jr. unveils new nutrition guidelines, pushing more protein, less processed food
Wed, Jan 7th 2026
Health and Science
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.Â
Mon, Jan 5th 2026
2026 will bring GLP-1 weight loss pills: These stocks will benefit from new habits
Thu, Jan 1st 2026
Analysis
Lilly investors shouldn’t sweat rival Novo having the first obesity pill on sale
Tue, Dec 23rd 2025
Pharmaceuticals
Wegovy-maker Novo Nordisk shares surge after GLP-1 weight loss pill approval
Tue, Dec 23rd 2025
Biotech and Pharma
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Mon, Dec 22nd 2025
Load More
